HIMS News and Press, Hims & Hers Health Inc. Class A

New York, New York--(Newsfile Corp. - July 17, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company's senior executives for potential violations of the federal se...

2025-07-16 08:45:00 ET Hims & Hers Health (NYSE: HIMS) is a top telehealth stock that has been growing its business rapidly in recent years. And one of the ways it has done that is by expanding into new markets and reaching a broader range of customers. Recently, it's lookin...

2025-07-16 07:56:28 ET More on Hims & Hers Health, Novo Nordisk Why Hims & Hers Management Might Be Its Most Valuable Asset Novo Nordisk: The Market Doesn't Get It Novo Nordisk: Reclaiming Market Share Market Voices: Copper tariffs, mortgage volumes r...

2025-07-15 23:09:36 ET Introduction and Investment Thesis I discovered the stock of Hims & Hers Health ( HIMS ) when it was trading around $20. Fortunately, I sold it with a 50% return but missed out on the following bullish run up to $50. In this article I will share ...

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter 2025 financial results after the market closes on Monday, August 4, 2025. The company will host a live conference call to discus...

If You Suffered Losses Exceeding $50,000 in Hims between April 29, 2025 and June 22, 2025 Securities Litigation Partner James (Josh) Wilson Encourages you to contact him directly at 877-247-4292 or 212-983-9330 (Ext. 1310) . [You may also click here to find out if you qualif...

New York, New York--(Newsfile Corp. - July 13, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company's senior executives for potential violations of the federal se...

2025-07-11 10:55:52 ET In my last article , I stated that the fear surrounding Novo Nordisk A/S ( NVO ); ( OTCPK:NONOF ) was overblown. At that time, concerns about competition and the sustainability of NVO's growth in their weight loss segment dimmed investors' confidence. The ...

2025-07-10 08:30:24 ET Palm Beach, FL – July 10, 2025 – The global telehealth market has been substantially growing over the past years and is expected to continue this growth well into the future. A report from Grand View Research said that: “The global telehea...

2025-07-09 12:26:41 ET More on Hims & Hers Health, Novo Nordisk, etc. H1 2025: Alternatives Served Me Well, But Underperformed What Will Investors Do With $7.4 Trillion? Novo Nordisk: Reclaiming Market Share AllianceBernstein flags an uneasy calm as globa...